Chimerix, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CMRX Company Description
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
CMRX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CMRX Smart Score
Score Breakdown
CMRX Company Description
Show More
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CMRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CMRX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CMRX in WallStreetBets Daily Discussion
CMRX News
Recent insights relating to CMRX
CNBC Recommendations
Recent picks made for CMRX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CMRX
Corporate Flights
Flights by private jets registered to CMRX
Our Analysis